Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion

Olga Pletnikova, Kelly L. Sloane, Alan E. Renton, Bryan J. Traynor, Barbara J. Crain, Tammy Reid, Tao Zu, Laura P W Ranum, Juan C Troncoso, Peter V Rabins, Chiadikaobi U Onyike

Research output: Contribution to journalArticle

Abstract

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are the main syndromes of the chromosome 9 ORF72 (C9ORF72) hexanucleotide repeat expansion, but studies have shown a substantial phenotypic diversity that includes psychiatric presentations. This study describes hippocampal sclerosis dementia (HSD) in carriers of the C9ORF72 mutation. We compared clinical and neuropathological features of HSD in carriers and noncarriers autopsied at Johns Hopkins. Carriers presented with amnesia, agitation, dissocial behavior, and impaired self-care, whereas noncarriers showed little agitation. The groups were not dissimilar in cognitive or motor dysfunction. Neuropathological examination of carriers showed cerebellar neuronal inclusions positive for ubiquitin, p62, and ubiquilin-2, and negative for TAR DNA-binding protein 43. Noncarriers did not have cerebellar inclusions. C9ORF72 repeat-associated non-ATG translation was confirmed by immunohistochemistry. These observations broaden the C9ORF72 phenotype and place HSD in the FTD spectrum. The amnesic phenotype of HSD, which is consistent with the focal hippocampal atrophy, should be included in clinical categorizations of FTD.

Original languageEnglish (US)
JournalNeurobiology of Aging
Volume35
Issue number10
DOIs
StatePublished - 2014

Fingerprint

Chromosomes, Human, Pair 9
Sclerosis
Dementia
Frontotemporal Dementia
Phenotype
Amnesia
DNA-Binding Proteins
Self Care
Ubiquitin
Atrophy
Psychiatry
Immunohistochemistry
Mutation

Keywords

  • C9ORF72 hexanucleotide repeat expansion
  • Dementia
  • Frontotemporal dementia
  • Hippocampal sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion. / Pletnikova, Olga; Sloane, Kelly L.; Renton, Alan E.; Traynor, Bryan J.; Crain, Barbara J.; Reid, Tammy; Zu, Tao; Ranum, Laura P W; Troncoso, Juan C; Rabins, Peter V; Onyike, Chiadikaobi U.

In: Neurobiology of Aging, Vol. 35, No. 10, 2014.

Research output: Contribution to journalArticle

Pletnikova, Olga ; Sloane, Kelly L. ; Renton, Alan E. ; Traynor, Bryan J. ; Crain, Barbara J. ; Reid, Tammy ; Zu, Tao ; Ranum, Laura P W ; Troncoso, Juan C ; Rabins, Peter V ; Onyike, Chiadikaobi U. / Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion. In: Neurobiology of Aging. 2014 ; Vol. 35, No. 10.
@article{05135cdb086b4846a7cba9471c1ac061,
title = "Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion",
abstract = "Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are the main syndromes of the chromosome 9 ORF72 (C9ORF72) hexanucleotide repeat expansion, but studies have shown a substantial phenotypic diversity that includes psychiatric presentations. This study describes hippocampal sclerosis dementia (HSD) in carriers of the C9ORF72 mutation. We compared clinical and neuropathological features of HSD in carriers and noncarriers autopsied at Johns Hopkins. Carriers presented with amnesia, agitation, dissocial behavior, and impaired self-care, whereas noncarriers showed little agitation. The groups were not dissimilar in cognitive or motor dysfunction. Neuropathological examination of carriers showed cerebellar neuronal inclusions positive for ubiquitin, p62, and ubiquilin-2, and negative for TAR DNA-binding protein 43. Noncarriers did not have cerebellar inclusions. C9ORF72 repeat-associated non-ATG translation was confirmed by immunohistochemistry. These observations broaden the C9ORF72 phenotype and place HSD in the FTD spectrum. The amnesic phenotype of HSD, which is consistent with the focal hippocampal atrophy, should be included in clinical categorizations of FTD.",
keywords = "C9ORF72 hexanucleotide repeat expansion, Dementia, Frontotemporal dementia, Hippocampal sclerosis",
author = "Olga Pletnikova and Sloane, {Kelly L.} and Renton, {Alan E.} and Traynor, {Bryan J.} and Crain, {Barbara J.} and Tammy Reid and Tao Zu and Ranum, {Laura P W} and Troncoso, {Juan C} and Rabins, {Peter V} and Onyike, {Chiadikaobi U}",
year = "2014",
doi = "10.1016/j.neurobiolaging.2014.04.009",
language = "English (US)",
volume = "35",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion

AU - Pletnikova, Olga

AU - Sloane, Kelly L.

AU - Renton, Alan E.

AU - Traynor, Bryan J.

AU - Crain, Barbara J.

AU - Reid, Tammy

AU - Zu, Tao

AU - Ranum, Laura P W

AU - Troncoso, Juan C

AU - Rabins, Peter V

AU - Onyike, Chiadikaobi U

PY - 2014

Y1 - 2014

N2 - Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are the main syndromes of the chromosome 9 ORF72 (C9ORF72) hexanucleotide repeat expansion, but studies have shown a substantial phenotypic diversity that includes psychiatric presentations. This study describes hippocampal sclerosis dementia (HSD) in carriers of the C9ORF72 mutation. We compared clinical and neuropathological features of HSD in carriers and noncarriers autopsied at Johns Hopkins. Carriers presented with amnesia, agitation, dissocial behavior, and impaired self-care, whereas noncarriers showed little agitation. The groups were not dissimilar in cognitive or motor dysfunction. Neuropathological examination of carriers showed cerebellar neuronal inclusions positive for ubiquitin, p62, and ubiquilin-2, and negative for TAR DNA-binding protein 43. Noncarriers did not have cerebellar inclusions. C9ORF72 repeat-associated non-ATG translation was confirmed by immunohistochemistry. These observations broaden the C9ORF72 phenotype and place HSD in the FTD spectrum. The amnesic phenotype of HSD, which is consistent with the focal hippocampal atrophy, should be included in clinical categorizations of FTD.

AB - Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are the main syndromes of the chromosome 9 ORF72 (C9ORF72) hexanucleotide repeat expansion, but studies have shown a substantial phenotypic diversity that includes psychiatric presentations. This study describes hippocampal sclerosis dementia (HSD) in carriers of the C9ORF72 mutation. We compared clinical and neuropathological features of HSD in carriers and noncarriers autopsied at Johns Hopkins. Carriers presented with amnesia, agitation, dissocial behavior, and impaired self-care, whereas noncarriers showed little agitation. The groups were not dissimilar in cognitive or motor dysfunction. Neuropathological examination of carriers showed cerebellar neuronal inclusions positive for ubiquitin, p62, and ubiquilin-2, and negative for TAR DNA-binding protein 43. Noncarriers did not have cerebellar inclusions. C9ORF72 repeat-associated non-ATG translation was confirmed by immunohistochemistry. These observations broaden the C9ORF72 phenotype and place HSD in the FTD spectrum. The amnesic phenotype of HSD, which is consistent with the focal hippocampal atrophy, should be included in clinical categorizations of FTD.

KW - C9ORF72 hexanucleotide repeat expansion

KW - Dementia

KW - Frontotemporal dementia

KW - Hippocampal sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84903819451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903819451&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2014.04.009

DO - 10.1016/j.neurobiolaging.2014.04.009

M3 - Article

C2 - 24819148

AN - SCOPUS:84903819451

VL - 35

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 10

ER -